Search

Your search keyword '"Joly, Francisca"' showing total 802 results
Start Over Author "Joly, Francisca"
802 results on '"Joly, Francisca"'

2. Efficacy and safety of apraglutide in short bowel syndrome with intestinal failure and colon–in–continuity: A multicenter, open-label, metabolic balance study

Author

Verbiest, Astrid, Hvistendahl, Mark Krogh, Bolognani, Federico, Li, Carrie, Youssef, Nader N., Huh, Susanna, Menys, Alex, Bhatnagar, Gauraang, Vanslembrouck, Ragna, Peeters, Ronald, Sartoris, Riccardo, Vermeersch, Pieter, Wauters, Lucas, Verbeke, Kristin, Jeppesen, Palle Bekker, Joly, Francisca, and Vanuytsel, Tim

Published
2024
Full Text
View/download PDF

8. The science of micronutrients in clinical practice – Report on the ESPEN symposium

Author

Berger, Mette M., Amrein, Karin, Barazzoni, Rocco, Bindels, Laure, Bretón, Irene, Calder, Philip C., Cappa, Stefano, Cuerda, Cristina, D'Amelio, Patrizia, de Man, Angélique, Delzenne, Nathalie M., Forbes, Alastair, Genton, Laurence, Gombart, Adrian F., Joly, Francisca, Laviano, Alessandro, Matthys, Christophe, Phyo, Pyi Pyi, Ravasco, Paula, Serlie, Mireille J., Shenkin, Alan, Stoffel, Nicole U., Talwar, Dinesh, and van Zanten, Arthur R.H.

Published
2024
Full Text
View/download PDF

13. COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure

Author

Pironi, Loris, Jezerski, Denise, Sobocki, Jacek, Lal, Simon, Vanuytsel, Tim, Theilla, Miriam, Sasdelli, Anna S., Chambrier, Cecile, Matysiak, Konrad, Aimasso, Umberto, Rasmussen, Henrik H., Jukes, Amelia, Kunecki, Marek, Seguy, David, Schneider, Stéphane M., Daniels, Joanne, Poullenot, Florian, Mundi, Manpreet S., Matras, Przemysław, Folwarski, Marcin, Crivelli, Adriana, Wyer, Nicola, Ellegard, Lars, Santarpia, Lidia, Arvanitakis, Marianna, Spaggiari, Corrado, Lamprecht, Georg, Guglielmi, Francesco W., Lezo, Antonella, Layec, Sabrina, Boluda, Esther Ramos, Guz-Mark, Anat, Gandullia, Paolo, Cuerda, Cristina, Osland, Emma, Spagnuolo, Maria I., Krznaric, Zeljko, Masconale, Luisa, Chapman, Brooke, Maíz-Jiménez, María, Orlandoni, Paolo, Martins da Rocha, Mariana Hollanda, Virgili-Casas, M. Nuria, Doitchinova-Simeonova, Maryana, Czako, Laszlo, Van Gossum, Andrè, D'Antiga, Lorenzo, Ee, Looi C., Warodomwichit, Daruneewan, Taus, Marina, Kolaček, Sanja, Thibault, Ronan, Verlato, Giovanna, Serralde-Zúñiga, Aurora E., Botella-Carretero, José I., Aguayo, Pilar Serrano, Olveira, Gabriel, Chomtho, Sirinuch, Pisprasert, Veeradej, Moisejevs, Georgijs, Murillo, Ana Zugasti, Jáuregui, M<ce:sup loc='post">a</ce:sup> Estrella Petrina, Díez, Marta Bueno, Jahit, Mohammad Shukri, Densupsoontorn, Narumon, Tamer, Ali, Brillanti, Giorgia, and Joly, Francisca

Published
2023
Full Text
View/download PDF

15. ESPEN guideline on Clinical Nutrition in inflammatory bowel disease

Author

Bischoff, Stephan C., Bager, Palle, Escher, Johanna, Forbes, Alastair, Hébuterne, Xavier, Hvas, Christian Lodberg, Joly, Francisca, Klek, Stansilaw, Krznaric, Zeljko, Ockenga, Johann, Schneider, Stéphane, Shamir, Raanan, Stardelova, Kalina, Bender, Darija Vranesic, Wierdsma, Nicolette, and Weimann, Arved

Published
2023
Full Text
View/download PDF

20. The EFFect of dietary fat content on the recurrence of pancreaTitis (EFFORT): Protocol of a multicenter randomized controlled trial

Author

Juhász, Márk Félix, Vereczkei, Zsófia, Ocskay, Klementina, Szakó, Lajos, Farkas, Nelli, Szakács, Zsolt, Zádori, Noémi, Wilschanski, Michael, Pandol, Stephen J., Joly, Francisca, Capurso, Gabriele, Arcidiacono, Paolo Giorgio, Izbéki, Ferenc, Czakó, László, Papp, Mária, Czopf, László, Hegyi, Péter, and Párniczky, Andrea

Published
2022
Full Text
View/download PDF

22. Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey

Author

Crivelli, Adriana N., Muñiz, Hector Solar, Chapman, Brooke R., Jones, Lynn, O'Callaghan, Margie, Osland, Emma, Hodgson, Ruth, Wallin, Siobhan, Lasenby, Kay, Van Gossum, Andre, Won Lee, Andre Dong, Doitchinova-Simeonova, Maryana, Krznaric, Zeljko, Rasmussen, Henrik Højgaard, Brandt, Chrisoffer, Jeppesen, Palle B., Chambrier, Cecile, Joly, Francisca, Boehm, Vanessa, Bataille, Julie, Billiauws, Lore, Poullenot, Florian, Schneider, Stéphane M., Seguy, David, Thibault, Ronan, Arends, Jann, Czako, Laszlo, Molnar, Tomas, Zsilak-Urban, Mihaly, Izbéki, Ferenc, Sahin, Peter, Udvarhelyi, Gábor, Schafer, Eszter, Theilla, Miriam, Sasdelli, Anna Simona, Brillanti, Giorgia, Nardi, Elena, Pironi, Loris, Aimasso, Umberto, Dario, Merlo F., Bertasi, Valentino, Masconale, Luisa, Guglielmi, Francesco W., Regano, Nunzia, Orlandoni, Paolo, Lidia, Santarpia, Alfonsi, Lucia, Spaggiari, Corrado, Taus, Marina, Busni, Debora, Kekstas, Gintautas, Serralde-Zúñiga, Aurora E., Gillanders, Lyn, Kunecki, Marek, Matras, Przemysław, Matysiak, Konrad, Szczepanek, Kinga, Zmarzly, Anna, Kozjek, Nada Rotovnik, Bueno, Marta, Cuerda, Cristina, Garde, Carmen, Virgili, Nuria M., Olveira, Gabriel, Jáuregui, M<ce:sup loc='post">a</ce:sup> Estrella Petrina, Sanz-Paris, Alejandro, Suárez-Llanos, José P., Murillo, Ana Zugasti, Ellegard, Lars, Serlie, Mireille, Jonker, Cora, Wanten, Geert, Cooper, Sheldon C., Daniels, Joanne, Di Caro, Simona, Keane, Niamh, Patel, Pinal, Forbes, Alastair, Nelson Hughes, Sarah-Jane, Jukes, Amelia, Lloyd, Rachel, Lal, Simon, Abraham, Arun, Garside, Gerda, Taylor, Michael, Wu, Jian, Smith, Trevor, Pither, Charlotte, Stroud, Michael, Wyer, Nicola, Parmar, Reena, Burch, Nicola, Zeraschi, Sarah, Compher, Charlene, Mundi, Manpreet, Jezerski, Denise, Steiger, Ezra, Sasdelli, Anna S., Mundi, Manpreet S., Rasmussen, Henrik H., Crivelli, Adriana, Santarpia, Lidia, Van Gossum, Andrè, Chapman, Brooke, Won Lee, Andre D., Díez, Marta Bueno, Jáuregui, Mª Estrella Petrina, and Youssef, Nader N.

Published
2021
Full Text
View/download PDF

27. Emerging drugs for the treatment of short bowel syndrome.

Author

Frau, Tristan, El Khatib, Myriam, De Dreuille, Brune, Billiauws, Lore, Nuzzo, Alexandre, and Joly, Francisca

Abstract

Introduction: SBS is a rare and disabling condition. The standard management is based on diet optimization with parenteral supplementation. In addition, glucagon-like peptide-2 (GLP-2)analogs, have shown promising results as disease-modifying therapies for SBS. Areas Covered: Short bowel syndrome (SBS) is defined as a reduction in functional intestinal length to less than 200 cm, leading to intestinal failure (IF) leading to malnutrition and parenteral support dependency. This review discusses the current management of SBS-CIFpatients, the place of GLP-2 analog treatment in terms of efficacy, safety and availability, and the new perspectives opened by the use of enterohormones. Expert Opinion: Clinical trials and real-world experience demonstrated that Teduglutide reduces dependence on parenteral support and has a place in the management of patients with SBS-CIF. The use of Teduglutide should be discussed in patients stabilized after resection and its introduction requires the advice of an expert center capable of assessing the benefit-risk ratio. The complex, individualized management of SBS-C IF requires theexpertise of a specialized IF center which a multidisciplinary approach. The arrival of new treatments will call for new therapeutic strategies, and the question of how to introduce and monitor them will represent a new therapeutic challenge. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

30. How the Covid-19 epidemic is challenging our practice in clinical nutrition--feedback from the field

Author

Thibault, Ronan, Coëffier, Moïse, Joly, Francisca, Bohé, Julien, Schneider, Stéphane M., and Déchelotte, Pierre

Subjects
Care and treatment, Methods, COVID-19 -- Care and treatment, Artificial nutrition -- Methods, Artificial feeding -- Methods
Abstract

Author(s): Ronan Thibault [sup.1] , Moïse Coëffier [sup.2] , Francisca Joly [sup.3] , Julien Bohé [sup.4] , Stéphane M. Schneider [sup.5] , Pierre Déchelotte [sup.2] Author Affiliations: (1) Unité de [...], The viral epidemic caused by the new Coronavirus SARS-CoV-2 is responsible for the new Coronavirus disease-2019 (Covid-19). Fifteen percent of the Covid-19 patients will require hospital stay, and 10% of them will need urgent respiratory and hemodynamic support in the intensive care unit (ICU). Covid-19 is an infectious disease characterized by inflammatory syndrome, itself leading to reduced food intake and increased muscle catabolism. Therefore Covid-19 patients are at high risk of being malnourished, making the prevention of malnutrition and the nutritional management key aspects of care. Urgent, brutal and massive arrivals of patients needing urgent respiratory care and artificial ventilation lead to the necessity to reorganize hospital care, wards and staff. In that context, nutritional screening and care may not be considered a priority. Moreover, at the start of the epidemic, due to mask and other protecting material shortage, the risk of healthcare givers contamination have led to not using enteral nutrition, although indicated, because nasogastric tube insertion is an aerosol-generating procedure. Clinical nutrition practice based on the international guidelines should therefore adapt and the use of degraded procedures could unfortunately be the only way. Based on the experience from the first weeks of the epidemic in France, we emphasize ten challenges for clinical nutrition practice. The objective is to bring objective answers to the most frequently met issues to help the clinical nutrition caregivers to promote nutritional care in the hospitalized Covid-19 patient. We propose a flow chart for optimizing the nutrition management of the Covid-19 patients in the non-ICU wards.

Published
2021
Full Text
View/download PDF

32. ESPEN guideline on home parenteral nutrition

Author

Pironi, Loris, Boeykens, Kurt, Bozzetti, Federico, Joly, Francisca, Klek, Stanislaw, Lal, Simon, Lichota, Marek, Mühlebach, Stefan, Van Gossum, Andre, Wanten, Geert, Wheatley, Carolyn, and Bischoff, Stephan C.

Published
2020
Full Text
View/download PDF

33. Adaptations de la prise en charge des patients en nutrition artificielle à domicile au cours de l’épidémie virale COVID-19 en France : avis du Comité de nutrition à domicile de la Société Francophone de Nutrition Clinique et Métabolisme (SFNCM)

Author

Schneider, Stéphane M., Albert, Véronique, Barbier, Nathalie, Barnoud, Didier, Bouteloup, Corinne, Chambrier, Cécile, Fayemendy, Philippe, Flori, Nicolas, Goulet, Olivier, Guimber, Dominique, Jirka, Adam, Joly, Francisca, Lescut, Dominique, Neuville, Sébastien, Piquet, Marie-Astrid, Poullenot, Florian, Quilliot, Didier, Séguy, David, Stocco, Jeanick, Thibault, Ronan, and Déchelotte, Pierre

Published
2020
Full Text
View/download PDF

34. EFFICACY AND SAFETY OF APRAGLUTIDE ONCE-WEEKLY IN PATIENTS WITH SHORT BOWEL SYNDROME AND INTESTINAL FAILURE (SBS-IF): RESULTS FROM THE STARS STUDY - A GLOBAL PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

Author

Joly, Francisca, primary, Vanuytsel, Tim, additional, Kirby, Donald F., additional, Lal, Simon, additional, Tappenden, Kelly, additional, Jeppesen, Palle B., additional, Youssef, Nader N., additional, Li, Carrie, additional, Sheik, Reda, additional, Statovci, Isabelle, additional, Huh, Susanna Y., additional, Bolognani, Federico, additional, and Iyer, Kishore R., additional

Published
2024
Full Text
View/download PDF

37. Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: An international survey

Author

Pironi, Loris, Steiger, Ezra, Brandt, Chrisoffer, Joly, Francisca, Wanten, Geert, Chambrier, Cecile, Aimasso, Umberto, Sasdelli, Anna Simona, Zeraschi, Sarah, Kelly, Darlene, Szczepanek, Kinga, Jukes, Amelia, Di Caro, Simona, Theilla, Miriam, Kunecki, Marek, Daniels, Joanne, Serlie, Mireille, Poullenot, Florian, Wu, Jian, Cooper, Sheldon C., Rasmussen, Henrik H., Compher, Charlene, Seguy, David, Crivelli, Adriana, Pagano, Maria C., Hughes, Sarah-Jane, Guglielmi, Francesco W., Kozjek, Nada Rotovnik, Schneider, Stéphane M., Gillanders, Lyn, Ellegard, Lars, Thibault, Ronan, Matras, Przemysław, Zmarzly, Anna, Matysiak, Konrad, Van Gossum, Andrè, Forbes, Alastair, Wyer, Nicola, Taus, Marina, Virgili, Nuria M., O'Callaghan, Margie, Chapman, Brooke, Osland, Emma, Cuerda, Cristina, Sahin, Peter, Jones, Lynn, Won Lee, Andre Dong, Masconale, Luisa, Orlandoni, Paolo, Izbéki, Ferenc, Spaggiari, Corrado, Bueno, Marta, Doitchinova-Simeonova, Maryana, Garde, Carmen, Serralde-Zúñiga, Aurora E., Olveira, Gabriel, Krznaric, Zeljko, Czako, Laszlo, Kekstas, Gintautas, Sanz-Paris, Alejandro, Jáuregui, Estrella Petrina, Murillo, Ana Zugasti, Schafer, Eszter, Arends, Jann, Suárez-Llanos, José P., and Lal, Simon

Published
2020
Full Text
View/download PDF

38. Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry

Author

Gondolesi, Gabriel E., Pape, Ulrich Frank, Mason, Joel B., Allard, Johane P., Pironi, Loris, Casas, María Núria Virgili, Schwartz, Lauren K., Joly, Francisca, Gabriel, André, Sabrdaran, Sasan, Zhang, Pinggao, Kohl-Sobania, Martina, Huang, Yi Wen, Jeppesen, Palle B., Gondolesi, Gabriel E., Pape, Ulrich Frank, Mason, Joel B., Allard, Johane P., Pironi, Loris, Casas, María Núria Virgili, Schwartz, Lauren K., Joly, Francisca, Gabriel, André, Sabrdaran, Sasan, Zhang, Pinggao, Kohl-Sobania, Martina, Huang, Yi Wen, and Jeppesen, Palle B.

Abstract

The Short Bowel Syndrome (SBS) Registry (NCT01990040) is a multinational real-world study evaluating the long-term safety of teduglutide in patients with SBS and intestinal failure (SBS-IF) in routine clinical practice. This paper describes the study methodology and baseline characteristics of adult patients who have (ever-treated) or have never (never-treated) received teduglutide. A total of 1411 adult patients (679 ever-treated; 732 never-treated) were enrolled at 124 sites across 17 countries. The mean (standard deviation [SD]) age at enrollment was 55.4 (15.46) years, and 60.2% of patients were women. Crohn’s disease was the most common cause of major intestinal resection in both ever-treated (34.1%) and never-treated patients (20.4%). A similar proportion of ever-treated and never-treated patients had a prior history of colorectal polyps (2.7% vs. 3.6%), whereas proportionally fewer ever-treated patients reported a history of colorectal cancer (1.8% vs. 6.2%) or any malignancy (17.7% vs. 30.0%) than never-treated patients. Never-treated patients received a numerically greater mean (SD) volume of parenteral nutrition and/or intravenous fluids than ever-treated patients (12.4 [8.02] vs. 10.1 [6.64] L/week). Ever-treated patients received a mean teduglutide dosage of 0.05 mg/kg/day. This is the first report of patient baseline characteristics from the SBS Registry, and the largest cohort of patients with SBS-IF to date. Overall, ever-treated and never-treated patients had similar baseline characteristics. Differences between treatment groups may reflect variations in patient selection and degree of monitoring.

Published
2024

39. Corrigendum to “Operational recommendations for the implementation of home parenteral nutrition program of care according to the guidelines of the European society for clinical nutrition and metabolism” [Clin Nutr ESPEN 63 (2024) 668–675, (S2405457724012609), (10.1016/j.clnesp.2024.07.1056)]

Author

Pironi, Loris, Cuerda, Cristina, Jeppesen, Palle Bekker, Joly, Francisca, Lal, Simon, Lamprecht, Georg, Mundi, Manpreet S., Szczepanek, Kinga, Gossum, André Van, Vanuytsel, Tim, Wanten, Geert, Weimann, Arved, Bischoff, Stephan C., Pironi, Loris, Cuerda, Cristina, Jeppesen, Palle Bekker, Joly, Francisca, Lal, Simon, Lamprecht, Georg, Mundi, Manpreet S., Szczepanek, Kinga, Gossum, André Van, Vanuytsel, Tim, Wanten, Geert, Weimann, Arved, and Bischoff, Stephan C.

Abstract

The authors regret some incorrect wording on the funding statement on page 675. This paper did not receive any specific funding from the public, commercial, or not-for-profit sectors. The Medical Nutrition International Industry (“MNI”) is providing funding support to this project only in relation to the follow-up dissemination of the content of this publication and not for the devising and publishing it. The authors would like to apologise for any inconvenience caused.

Published
2024

40. Efficacy and safety of apraglutide in short bowel syndrome with intestinal failure and colon–in–continuity:A multicenter, open-label, metabolic balance study

Author

Verbiest, Astrid, Hvistendahl, Mark Krogh, Bolognani, Federico, Li, Carrie, Youssef, Nader N., Huh, Susanna, Menys, Alex, Bhatnagar, Gauraang, Vanslembrouck, Ragna, Peeters, Ronald, Sartoris, Riccardo, Vermeersch, Pieter, Wauters, Lucas, Verbeke, Kristin, Jeppesen, Palle Bekker, Joly, Francisca, Vanuytsel, Tim, Verbiest, Astrid, Hvistendahl, Mark Krogh, Bolognani, Federico, Li, Carrie, Youssef, Nader N., Huh, Susanna, Menys, Alex, Bhatnagar, Gauraang, Vanslembrouck, Ragna, Peeters, Ronald, Sartoris, Riccardo, Vermeersch, Pieter, Wauters, Lucas, Verbeke, Kristin, Jeppesen, Palle Bekker, Joly, Francisca, and Vanuytsel, Tim

Abstract

Background: Apraglutide is a novel long-acting GLP-2 analog in development for short bowel syndrome with intestinal failure (SBS-IF). This multicenter, open-label, phase 2 study in SBS-IF and colon-in-continuity (CiC) investigates the safety and efficacy of apraglutide. Methods: This was a 52-week phase 2 metabolic balance study (MBS) in 9 adult patients with SBS-IF-CiC receiving once-weekly subcutaneous apraglutide injections. Safety was the primary endpoint. Secondary endpoints included changes in absorption parameters (MBS at baseline, after 4 weeks with stable parenteral support (PS), and 48 weeks), PS needs (48-week PS adjustment period based on monthly 48-h fluid balances) and intestinal morphology and motility (static and cine MRI at baseline and 4, 24 and 48 weeks). Results: PS volume decreased by −4702 mL/week (−52 %; p < 0.001) at week 52. Seven patients (78 %) achieved ≥1 day off PS at week 52. At 4 weeks, fecal output was reduced by 253 g/day (p = 0.013). At 48 weeks, increases in wet weight absorption by 316 g/day (p = 0.039), energy absorption by 1134 kJ/day (p = 0.041) and carbohydrate absorption by 56.1 g/day (p = 0.024) were observed. Moreover, small bowel length increased from 29.7 to 40.7 cm (p = 0.012), duodenal wall thickness increased by 0.8 mm (p = 0.02) and motility in the proximal colon was reduced (p = 0.031). A total of 127 adverse events was reported, which were mostly mild to moderate. Conclusion: Apraglutide had an acceptable safety profile and was associated with significant reductions in PS needs and days off PS, improvements in intestinal absorption, and structural and functional intestinal changes in patients with SBS-IF-CiC. ClinicalTrials.gov, Number NCT04964986.

Published
2024

41. An international study of the quality of life of adult patients treated with home parenteral nutrition

Author

Baxter, Janet P., Fayers, Peter M., Bozzetti, Federico, Kelly, Darlene, Joly, Francisca, Wanten, Geert, Jonkers, Cora, Cuerda, Cristina, van Gossum, Andre, Klek, Stanislaw, Boudreault, Marie-France, Gilbert, Alain, Jobin, Manon, Staun, Michael, Gillanders, Lyn, Forbes, Alastair, O'Callaghan, Margie, Faedo, Ceferino Martínez, Brunelli, Cinzia, Mariani, Luigi, and Pironi, Loris

Published
2019
Full Text
View/download PDF

42. MyoNeuroGastroIntestinal Encephalopathy: Natural History and Means for Early Diagnosis

Author

Seguy, David, Acquaviva-Bourdain, Cécile, Bouhour, Francoise, Gaignard, Pauline, Slama, Abdelhamid, Roubertie, Agathe, Morales, Raul Juntas, Barth, Magalie, Cintas, Pascal, Bereau, Matthieu, Campana-Salort, Emmanuelle, Ogier de Baulny, Hélène, Schiff, Manuel, Benoist, Jean-François, Corne, Christelle, Joly, Francisca, Corazza, Giovanni, Pagan, Cécile, Hardy, Gaëlle, Besson, Gérard, and Lombès, Anne

Published
2019
Full Text
View/download PDF

45. The Science of Micronutrients in Clinical Practice – Report on the ESPEN symposium

Author

Berger, Mette M., primary, Amrein, Karin, additional, Barazzoni, Rocco, additional, Bindels, Laure, additional, Bretón, Irene, additional, Calder, Philip C., additional, Cappa, Stefano, additional, Cuerda, Cristina, additional, D’Amelio, Patrizia, additional, de Man, Angélique, additional, Delzenne, Nathalie M., additional, Forbes, Alastair, additional, Genton, Laurence, additional, Gombart, Adrian F., additional, Joly, Francisca, additional, Laviano, Alessandro, additional, Matthys, Christophe, additional, Phyo, Pyi Pyi, additional, Ravasco, Paula, additional, Serlie, Mireille J., additional, Shenkin, Alan, additional, Stoffel, Nicole U., additional, Talwar, Dinesh, additional, and van Zanten, Arthur R.H., additional

Published
2023
Full Text
View/download PDF

48. Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure

Author

Joly, Francisca, Baxter, Janet, Staun, Michael, Kelly, Darlene G., Hwa, Yi Lisa, Corcos, Olivier, De Francesco, Antonella, Agostini, Federica, Klek, Stanislaw, Santarpia, Lidia, Contaldo, Franco, Jonker, Cora, Wanten, Geert, Chicharro, Luisa, Burgos, Rosa, Van Gossum, Andre, Cuerda, Cristina, Virgili, Nuria, and Pironi, Loris

Published
2018
Full Text
View/download PDF

49. Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey

Author

Pironi, Loris, Konrad, Denise, Brandt, Chrisoffer, Joly, Francisca, Wanten, Geert, Agostini, Federica, Chambrier, Cecile, Aimasso, Umberto, Zeraschi, Sarah, Kelly, Darlene, Szczepanek, Kinga, Jukes, Amelia, Di Caro, Simona, Theilla, Miriam, Kunecki, Marek, Daniels, Joanne, Serlie, Mireille, Poullenot, Florian, Wu, Jian, Cooper, Sheldon C., Rasmussen, Henrik H., Compher, Charlene, Seguy, David, Crivelli, Adriana, Pagano, Maria C., Hughes, Sarah-Jane, Guglielmi, Francesco W., Kozjek, Nada Rotovnik, Schneider, Stéphane M., Gillanders, Lyn, Ellegard, Lars, Thibault, Ronan, Matras, Przemysław, Zmarzly, Anna, Matysiak, Konrad, Van Gossum, Andrè, Forbes, Alastair, Wyer, Nicola, Taus, Marina, Virgili, Nuria M., O'Callaghan, Margie, Chapman, Brooke, Osland, Emma, Cuerda, Cristina, Sahin, Peter, Jones, Lynn, Lee, Andre D.W., Bertasi, Valentino, Orlandoni, Paolo, Izbéki, Ferenc, Spaggiari, Corrado, Díez, Marta Bueno, Doitchinova-Simeonova, Maryana, Garde, Carmen, Serralde-Zúñiga, Aurora E., Olveira, Gabriel, Krznaric, Zeljko, Czako, Laszlo, Kekstas, Gintautas, Sanz-Paris, Alejandro, Jáuregui, Estrella Petrina, Murillo, Ana Zugasti, Schafer, Eszter, Arends, Jann, Suárez-Llanos, José P., Shaffer, Jon, and Lal, Simon

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results